Logo image of BLEE.PA

BLEECKER (BLEE.PA) Stock Fundamental Analysis

EPA:BLEE - Euronext Paris - Matif - FR0000062150 - Common Stock - Currency: EUR

122  -2 (-1.61%)

Fundamental Rating

2

Taking everything into account, BLEE scores 2 out of 10 in our fundamental rating. BLEE was compared to 41 industry peers in the Diversified REITs industry. BLEE has a bad profitability rating. Also its financial health evaluation is rather negative. BLEE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BLEE has reported negative net income.
BLEE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLEE reported negative net income in multiple years.
In the past 5 years BLEE always reported a positive cash flow from operatings.
BLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFBLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

BLEE's Return On Assets of -6.98% is on the low side compared to the rest of the industry. BLEE is outperformed by 90.24% of its industry peers.
With a Return On Equity value of -15.94%, BLEE is not doing good in the industry: 90.24% of the companies in the same industry are doing better.
BLEE has a Return On Invested Capital of 1.50%. This is amonst the worse of the industry: BLEE underperforms 85.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLEE is below the industry average of 3.55%.
The last Return On Invested Capital (1.50%) for BLEE is above the 3 year average (0.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.98%
ROE -15.94%
ROIC 1.5%
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
BLEE.PA Yearly ROA, ROE, ROICBLEE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

BLEE has a Operating Margin of 38.10%. This is in the lower half of the industry: BLEE underperforms 78.05% of its industry peers.
BLEE's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 46.11%, BLEE is not doing good in the industry: 78.05% of the companies in the same industry are doing better.
BLEE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 38.1%
PM (TTM) N/A
GM 46.11%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
BLEE.PA Yearly Profit, Operating, Gross MarginsBLEE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLEE is destroying value.
Compared to 1 year ago, BLEE has about the same amount of shares outstanding.
Compared to 5 years ago, BLEE has about the same amount of shares outstanding.
BLEE has a better debt/assets ratio than last year.
BLEE.PA Yearly Shares OutstandingBLEE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
BLEE.PA Yearly Total Debt VS Total AssetsBLEE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

BLEE has an Altman-Z score of 0.92. This is a bad value and indicates that BLEE is not financially healthy and even has some risk of bankruptcy.
BLEE has a Altman-Z score (0.92) which is in line with its industry peers.
The Debt to FCF ratio of BLEE is 477.31, which is on the high side as it means it would take BLEE, 477.31 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BLEE (477.31) is worse than 80.49% of its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that BLEE has dependencies on debt financing.
BLEE's Debt to Equity ratio of 1.14 is on the low side compared to the rest of the industry. BLEE is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 477.31
Altman-Z 0.92
ROIC/WACC0.35
WACC4.31%
BLEE.PA Yearly LT Debt VS Equity VS FCFBLEE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BLEE has a Current Ratio of 0.87. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BLEE (0.87) is better than 65.85% of its industry peers.
BLEE has a Quick Ratio of 0.87. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.87, BLEE is doing good in the industry, outperforming 70.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
BLEE.PA Yearly Current Assets VS Current LiabilitesBLEE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

BLEE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.73%.
BLEE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.86%.
Measured over the past years, BLEE shows a small growth in Revenue. The Revenue has been growing by 7.33% on average per year.
EPS 1Y (TTM)-58.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.84%
Revenue 1Y (TTM)2.86%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%2.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLEE.PA Yearly Revenue VS EstimatesBLEE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLEE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLEE.PA Price Earnings VS Forward Price EarningsBLEE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLEE indicates a rather expensive valuation: BLEE more expensive than 80.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 209.51
EV/EBITDA N/A
BLEE.PA Per share dataBLEE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BLEE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLEECKER

EPA:BLEE (5/30/2025, 7:00:00 PM)

122

-2 (-1.61%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap137.86M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.6
P/FCF 209.51
P/OCF 17.09
P/B 0.53
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)-36.76
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.58
FCFY0.48%
OCF(TTM)7.14
OCFY5.85%
SpS26.51
BVpS229.43
TBVpS226.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.98%
ROE -15.94%
ROCE 2.04%
ROIC 1.5%
ROICexc 1.51%
ROICexgc 1.52%
OM 38.1%
PM (TTM) N/A
GM 46.11%
FCFM 2.2%
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
ROICexc(3y)0.99%
ROICexc(5y)0.84%
ROICexgc(3y)1%
ROICexgc(5y)0.84%
ROCE(3y)1.34%
ROCE(5y)1.13%
ROICexcg growth 3Y47.05%
ROICexcg growth 5Y20.23%
ROICexc growth 3Y47.05%
ROICexc growth 5Y20.22%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 477.31
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 24.73%
Interest Coverage 0.79
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.92
F-Score5
WACC4.31%
ROIC/WACC0.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.61%
Cap/Sales(5y)36.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.86%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%2.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.04%
EBIT growth 3Y45.94%
EBIT growth 5Y17.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-85.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.4%
OCF growth 3Y120.64%
OCF growth 5Y3.91%